| Net Cash Provided by (Used in) Operating Activities |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
75M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4.56M |
shares |
|
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
23.8K |
USD |
+23.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
108K |
USD |
+9.77% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability |
0 |
USD |
|
Q3 2024 |
Q3 2024 |
| Operating Lease, Liability, Current |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
108K |
USD |
+9.77% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
169K |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
508K |
USD |
+5.99% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
36.2K |
USD |
+418% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2025 |
Q3 2025 |